Dendritic spines are small actin-rich protrusions from neuronal dendrites that form the postsynaptic part of most excitatory synapses. Changes in the shape and size of dendritic spines correlate with the functional changes in excitatory synapses and are heavily dependent on the remodeling of the underlying actin cytoskeleton. Recent evidence implicates synapses at dendritic spines as important substrates of pathogenesis in neuropsychiatric disorders, including autism spectrum disorder (ASD). Although synaptic perturbations are not the only alterations relevant for these diseases, understanding the molecular underpinnings of the spine and synapse pathology may provide insight into their etiologies and could reveal new drug targets. In this review, we will discuss recent findings of defective actin regulation in dendritic spines associated with ASD.
A B S T R A C T
Dendritic spines are small actin-rich protrusions from neuronal dendrites that form the postsynaptic part of most excitatory synapses. Changes in the shape and size of dendritic spines correlate with the functional changes in excitatory synapses and are heavily dependent on the remodeling of the underlying actin cytoskeleton. Recent evidence implicates synapses at dendritic spines as important substrates of pathogenesis in neuropsychiatric disorders, including autism spectrum disorder (ASD). Although synaptic perturbations are not the only alterations relevant for these diseases, understanding the molecular underpinnings of the spine and synapse pathology may provide insight into their etiologies and could reveal new drug targets. In this review, we will discuss recent findings of defective actin regulation in dendritic spines associated with ASD.
Synaptic deficiency in autism spectrum disorder
Autism spectrum disorder (ASD) comprises a range of neurological conditions that affect the ability of individuals to communicate and interact with others. ASD is characterized by impaired social interactions, communication deficits, and repetitive behaviors. ASD is typically diagnosed during the first 3 years of life, a period of extensive neurite formation, synaptogenesis and refinement (Huttenlocher & Dabholkar, 1997; Zoghbi & Bear, 2012; Stamou et al., 2013; McGee et al., 2014) . Family and twin studies have revealed that ASD has a strong genetic component, with numerous genes being affected. In addition to mutations inherited from parents, many ASD-associated mutations are rare protein disrupting de novo mutations that have arisen in the germline. Mutations can be copy-number variants (CNVs) or single-base-pair mutations (de la Torre-Ubieta et al., 2016) . By definition, CNVs are deleted or duplicated segments of DNA (> 1000 basepairs) that are thought to be involved in the pathogenesis of a wide range of human diseases, including ASD. At least six recurrent CNVs are among the most frequently identified genetic contributors to ASD (Sanders et al., 2015) . Overall, there seems to be an enrichment in 'likely gene-disrupting' mutations (LGDs; nonsense, frameshift and splice site mutations that often result in the production of truncated proteins) in individuals with ASD as compared to their healthy relatives or to other unaffected individuals (de la Torre-Ubieta et al., 2016) .
Multiple ASD susceptibility genes converge on cellular pathways that intersect at the postsynaptic site of glutamatergic synapses (Bourgeron, 2015; Peca & Feng, 2012) , the development and maturation of synaptic contacts (Gilman et al., 2011) E-mail address: pirta.hotulainen@helsinki.fi (P. Hotulainen).
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